AU2001258550A1 - Insulin formulation for inhalation - Google Patents

Insulin formulation for inhalation

Info

Publication number
AU2001258550A1
AU2001258550A1 AU2001258550A AU5855001A AU2001258550A1 AU 2001258550 A1 AU2001258550 A1 AU 2001258550A1 AU 2001258550 A AU2001258550 A AU 2001258550A AU 5855001 A AU5855001 A AU 5855001A AU 2001258550 A1 AU2001258550 A1 AU 2001258550A1
Authority
AU
Australia
Prior art keywords
inhalation
insulin formulation
insulin
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258550A
Inventor
Jaap Kampinga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Quadrant Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Healthcare UK Ltd filed Critical Quadrant Healthcare UK Ltd
Publication of AU2001258550A1 publication Critical patent/AU2001258550A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001258550A 2000-05-16 2001-05-16 Insulin formulation for inhalation Abandoned AU2001258550A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0011807.5A GB0011807D0 (en) 2000-05-16 2000-05-16 Formulation for inhalation
GB0011807 2000-05-16
PCT/GB2001/002181 WO2001087278A1 (en) 2000-05-16 2001-05-16 Insulin formulation for inhalation

Publications (1)

Publication Number Publication Date
AU2001258550A1 true AU2001258550A1 (en) 2001-11-26

Family

ID=9891708

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258550A Abandoned AU2001258550A1 (en) 2000-05-16 2001-05-16 Insulin formulation for inhalation

Country Status (7)

Country Link
US (1) US20030148925A1 (en)
EP (1) EP1282409A1 (en)
JP (1) JP2003533472A (en)
AU (1) AU2001258550A1 (en)
CA (1) CA2407254A1 (en)
GB (1) GB0011807D0 (en)
WO (1) WO2001087278A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
DE60227691D1 (en) 2001-11-01 2008-08-28 Nektar Therapeutics SPRAY DRYING PROCESS
CA2468958C (en) 2001-12-19 2012-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB0304540D0 (en) * 2003-02-27 2003-04-02 Elan Drug Delivery Ltd Particle formulation and its preparation
JP2007534693A (en) 2004-04-23 2007-11-29 サイデックス・インコーポレイテッド DPI formulation containing sulfoalkyl ether cyclodextrin
EP1593376A1 (en) * 2004-05-04 2005-11-09 Warner-Lambert Company LLC Improved pullulan capsules
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
CA2677838C (en) 2007-02-11 2017-08-01 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
CA3215128A1 (en) * 2021-04-11 2022-10-20 Michal Olshansky Insulin formulations and methods of using same in preterm infants

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
IS1796B (en) * 1993-06-24 2001-12-31 Ab Astra Inhaled polypeptide formulation composition which also contains an enhancer compound
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
KR100419037B1 (en) * 1994-03-07 2004-06-12 넥타르 테라퓨틱스 Methods of delivery of insulin through the lungs and their composition
SE9404468D0 (en) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US6517860B1 (en) * 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
HUP0000547A3 (en) * 1997-03-20 2002-11-28 Novo Nordisk As Zinc free insulin crystals for use in pulmonary compositions
GB9814172D0 (en) * 1998-06-30 1998-08-26 Andaris Ltd Formulation for inhalation
US6451349B1 (en) * 1998-08-19 2002-09-17 Quadrant Healthcare (Uk) Limited Spray-drying process for the preparation of microparticles
GB0004827D0 (en) * 2000-02-29 2000-04-19 Quadrant Holdings Cambridge Compositions

Also Published As

Publication number Publication date
US20030148925A1 (en) 2003-08-07
JP2003533472A (en) 2003-11-11
GB0011807D0 (en) 2000-07-05
CA2407254A1 (en) 2001-11-22
EP1282409A1 (en) 2003-02-12
WO2001087278A1 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU2002248464A1 (en) Stabilized insulin formulations
AU2002330273A1 (en) Liposome-encapsulated insulin formulations
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU2002223028A1 (en) Inhaler
AU2002361453A1 (en) Metered dose inhaler
IL158862A0 (en) An insulin composition for pulmonary administration
WO2002089880A8 (en) Inhalers
AU2001248673A1 (en) Nasal inhaler
AU2002234476A1 (en) Medical aerosol formulations
AU2001295657A1 (en) Formulation containing wax-esters
AU2001274548A1 (en) Syringe
AU2002253039A1 (en) Tramadol-based medicament
AU2002223562A1 (en) Medicament dispenser
AU2002258221A1 (en) Medicinal composition
AU2001268750A1 (en) Flushed-seal respirator
AU2001290239A1 (en) Medicinal composition
AU2001258550A1 (en) Insulin formulation for inhalation
AU4417101A (en) Metered dose inhaler
AU2001256168A1 (en) Metered dose inhaler
AU4831801A (en) Metered dose inhaler
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU2001232244A1 (en) Drug comprising combination
AU4417001A (en) Metered dose inhaler
AU2001260236A1 (en) Restricted use syringe
AU2001267135A1 (en) Medicaments